Eden Raises $4.35m, Cuts Debt by $16m, Secures $514k EdenCrete Order

Eden Innovations has significantly reduced its debt burden and secured fresh capital, while expanding sales and trials of its advanced concrete additives across key international markets.

  • Raised AUD$4.35 million via placement including major shareholder participation
  • Reduced total debt by approximately AUD$16 million through repayments and conversions
  • Secured large EdenCrete®Pz7 order from Holcim Ecuador, with further US and Indian projects underway
  • OptiBlend sales gaining traction in US data centres and emerging markets in Africa and Middle East
  • Completed sale of Georgia property, applied proceeds to debt reduction, and secured convertible note to ease cash flow
An image related to EDEN INNOVATIONS LTD
Image source middle. ©

Financial Restructuring Nears Completion

Eden Innovations Ltd (ASX, EDE) has taken decisive steps to strengthen its balance sheet, completing a placement that raised AUD$4.35 million in December 2025. This capital injection, which included AUD$250,000 from major shareholder Noble Energy Pty Ltd, has been instrumental in the company’s broader financial reconstruction efforts. Since mid-2025, Eden has reduced its total debt by approximately AUD$16 million through a combination of loan repayments, debt refinancing, and loan-to-equity conversions.

Key to this progress was the sale of a property in Georgia, USA, which generated funds used to repay a significant portion of the high-interest iBorrow loan. Additionally, a strategic convertible note of AUD$2.2 million was secured from a major shareholder, replacing residual high-interest debt and easing quarterly cash outflows by capitalising interest rather than requiring cash repayments.

Strong Commercial Momentum for EdenCrete®Pz7

Eden’s flagship concrete additive, EdenCrete®Pz7, continues to gain traction internationally. Holcim Ecuador placed its largest order to date, valued at approximately AUD$514,000, marking the third substantial purchase since early 2024. This order will supply nine of Holcim’s largest concrete plants, with annual sales expected to grow to around AUD$1.2 million. The relationship with Holcim, a global leader in cement and concrete, underscores Eden’s product credibility and market potential.

In the United States, EdenCrete®Pz7 is being used in major infrastructure projects, including the Bellview Station Block F in Denver and the Colorado Department of Transportation’s I-70 Floyd Hill flyover bridge. Reports from contractors highlight enhanced concrete strength and reliable performance, aided by favourable weather conditions accelerating construction progress.

Meanwhile, Eden is advancing trials in India alongside the Central Road Research Institute. These tests focus on improving concrete flexural strength and reducing permeability in mixes used for highways and bridges. Success here could unlock access to India’s rapidly expanding national highway network, the world’s second largest, where the government is prioritising technology and sustainability to address past issues with sub-standard concrete.

OptiBlend Gains Traction in US and Emerging Markets

OptiBlend, Eden’s fuel blending technology, is also showing promising growth. In the US, nine orders worth USD$455,000 were secured in the first four months of FY26, including a notable order for a US court. The company reported nearly USD$265,000 in revenue for the quarter and holds live quotations exceeding USD$4 million, signalling strong pipeline demand.

Internationally, Eden is making early inroads into markets across Africa, the Middle East, and southern and western India. Discussions are underway in countries such as Nigeria, Lebanon, UAE, and South Africa, reflecting a strategic push to diversify and expand OptiBlend’s footprint beyond northern India, where competition from lower-cost alternatives has slowed growth.

Operational Cash Flow and Outlook

Despite these positive developments, Eden’s operating cash flow remains negative, with a net outflow of AUD$1.365 million for the quarter. However, the company’s cash reserves and available funding facilities provide a runway of approximately 2.7 quarters at current burn rates. The recent financial restructuring and capital raising efforts are expected to support Eden’s operational needs while it continues to scale sales and complete product trials.

Looking ahead, Eden’s progress in reducing debt and expanding its commercial footprint across multiple continents positions it well to pursue its goal of achieving positive cash flow in calendar year 2026. The outcomes of ongoing trials in India and the conversion of convertible notes into equity will be key milestones to watch.

Bottom Line?

Eden Innovations’ financial overhaul and expanding global sales pipeline set the stage for a pivotal year ahead.

Questions in the middle?

  • Will Eden’s trials in India translate into significant market penetration for EdenCrete®Pz7?
  • How will the conversion of convertible notes impact Eden’s share structure and investor sentiment?
  • Can Eden sustain operational cash flow improvements as it scales international sales?